YM BioSciences To Pursue Nimotuzumab Pediatric Brain Cancer Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Enrollment in a European Phase III trial for the mAb as a first-line treatment for pediatric diffuse intrinsic pontine glioma has initiated.